K1, MK-4 and MK-7 identify different forms
K1 is phylloquinone, found in leafy vegetables. K2 includes menaquinones such as MK-4 and MK-7; natto supplies menaquinones. MK-7’s longer persistence does not prove better clinical outcomes.See reference 1
The artwork pairs leafy greens, natto and an unbranded tablet to represent this form comparison. It does not specify the tablet’s ingredients. Record the named form, actual amount and any vitamin D or other ingredients before comparing a product with a study.
Separate nutrient function from supplement outcomes
- Question
- Usual intake reference
- Evidence observed
- Reference bodies set adequate intakes for a population
- Limit
- An adequate intake is not a separate K2 prescriptionSee reference 1,See reference 2
- Question
- Bone measures
- Evidence observed
- A three-year MK-7 trial reported reduced loss in some bone measures
- Limit
- It does not establish fracture prevention for every K2 preparationSee reference 3
- Question
- Aortic-valve calcification
- Evidence observed
- A two-year MK-7 plus vitamin D trial did not slow the primary calcification outcome
- Limit
- Improved vitamin-K-related biomarkers did not establish clinical efficacySee reference 4
- Question
- Medicine compatibility
- Evidence observed
- Vitamin K can seriously interact with vitamin K antagonist medicines
- Limit
- A formula change needs review by the clinician managing the medicineSee reference 1
Population reference values are not retail K2 targets
NIH lists U.S. adult adequate intakes of 120 micrograms/day for men and 90 for women, for total vitamin K. No established upper limit means uncertainty, not unlimited clearance.See reference 1
EFSA’s 2017 opinion set an adult adequate intake of 70 micrograms/day based on phylloquinone. It also identified gaps in menaquinone intake, metabolism and long-term outcome research. Different reference systems should not be silently combined into one personalised supplement amount.See reference 2
Read the bone trial as a specific experiment
A 2013 trial assigned 244 healthy postmenopausal women to placebo or 180 micrograms/day of MK-7 for three years. It reported less age-related decline at the lumbar spine and femoral neck, but not total hip, alongside improved vitamin K status. Those details belong together when a product cites the trial.See reference 3
Bone-density and strength measures are informative, but they cannot be rewritten as a demonstrated reduction in clinical fractures. The tested population, form and duration also do not establish a dose for every adult. The linked study is evidence to discuss, not a treatment instruction.See reference 3
A biomarker response did not clear the calcification claim
The 2022 trial enrolled 365 older men with aortic-valve calcification. MK-7 at 720 micrograms/day plus vitamin D at 25 micrograms/day was compared with placebo for 24 months. The primary calcification progression did not differ significantly, although a vitamin-K-dependent protein marker changed.See reference 4
This is a useful example of the distance between biochemical activity and a clinical claim. It does not justify a promise to remove calcium from arteries or a self-directed vascular-treatment plan. The studied combination also cannot isolate every possible effect of K2 alone.See reference 4
Keep micrograms and milligrams visible
A label in micrograms must not be compared as though it used milligrams. The metric relationship is exact: 1 milligram equals 1,000 micrograms. For example, 180 micrograms is 0.18 milligrams. This is a unit explanation, not a suggested intake.
NIH describes mixed bone trials, some using pharmacological MK-4 amounts in milligrams. Those protocols cannot automatically endorse a retail MK-7 product.See reference 1
Warfarin and vitamin K need a shared plan
Vitamin K can seriously interact with warfarin and related vitamin K antagonists. Report diet or supplement changes to the managing clinician; not every anticoagulant shares this mechanism.See reference 1
Keep a full ingredient label and the medicine name available for a pharmacist or clinician. This guide does not change a medicine dose, advise stopping greens or assess an individual’s coagulation result. Consistency and medication management require the actual clinical context.
Keep the useful details
- Identify K1, MK-4 or MK-7 rather than treating all forms as one product.
- Keep bone measurements separate from proven fracture prevention.See reference 3
- A biochemical response does not establish a calcification treatment.See reference 4
Common questions
Is there one established K2 intake target for all adults?
No. The cited reference values concern vitamin K overall or phylloquinone, rather than a universal retail K2 regimen.See reference 1,See reference 2
Does the bone trial prove that K2 prevents fractures?
Its reported bone measures do not establish that broader outcome for every formulation or population.See reference 3
Did MK-7 slow aortic-valve calcification in the cited trial?
The primary outcome did not differ significantly from placebo over two years.See reference 4
Does a longer half-life prove a better supplement?
It describes persistence in circulation. A clinical superiority claim needs an appropriate clinical comparison.
Can this guide approve K2 alongside warfarin?
No. Take the exact product label to the clinician managing the medicine; the guide cannot assess that combination.
Get the weekly longevity brief
The week's best longevity research in plain English. Free, every Tuesday.
References
- 1. Vitamin K: health professional fact sheet
NIH Office of Dietary SupplementsOfficial guidance
- 2. Dietary reference values for vitamin K
EFSA Panel on Dietetic Products, Nutrition and Allergies, 2017Official guidance
- 3. Three-year MK-7 trial: bone measures in postmenopausal women
Knapen et al., 2013; Osteoporosis InternationalRandomized trial
- 4. Vitamin K2 and vitamin D: aortic-valve calcification randomized trial
Diederichsen et al., 2022; CirculationRandomized trial
Editorial transparency
- Published by
- LongevityMate Editorial
- Published
- Updated
Medical disclaimer
Educational information about published research and product labels. This guide does not diagnose a condition, choose a supplement or dose, change a medicine, or replace advice from a qualified healthcare professional.
